Allen C. ChengWirongrong ChierakulWipada ChaowagulPloenchan ChetchotisakdDirek LimmathurotsakulDavid A.B. DanceSharon J. PeacockBart J. CurrieMenzies School of Health ResearchUniversity of MelbourneMahidol UniversitySappasitthiprasong HospitalKhon Kaen UniversityHealth Protection Agency South West2018-07-122018-07-122008-02-01American Journal of Tropical Medicine and Hygiene. Vol.78, No.2 (2008), 208-209000296372-s2.0-41249090879https://repository.li.mahidol.ac.th/handle/20.500.14594/19378Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia. In response to clinical confusion regarding the appropriate dose of amoxicillin-clavulanate, we have developed guidelines for the appropriate dosing of this second-line agent. For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily. Copyright © 2008 by The American Society of Tropical Medicine and Hygiene.Mahidol UniversityImmunology and MicrobiologyMedicineShort report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosisArticleSCOPUS